Cargando…

Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial

BACKGROUND: Laughter has been reported to have various health benefits. However, data on the long-term effects of laughter interventions on diabetes are limited. This study aimed to investigate whether laughter yoga can improve glycemic control among individuals with type 2 diabetes. METHODS: In a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirosaki, Mayumi, Ohira, Tetsuya, Wu, Yawei, Eguchi, Eri, Shirai, Kokoro, Imano, Hironori, Funakubo, Narumi, Nishizawa, Hitoshi, Katakami, Naoto, Shimomura, Iichiro, Iso, Hiroyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102335/
https://www.ncbi.nlm.nih.gov/pubmed/37065750
http://dx.doi.org/10.3389/fendo.2023.1148468
_version_ 1785025672778874880
author Hirosaki, Mayumi
Ohira, Tetsuya
Wu, Yawei
Eguchi, Eri
Shirai, Kokoro
Imano, Hironori
Funakubo, Narumi
Nishizawa, Hitoshi
Katakami, Naoto
Shimomura, Iichiro
Iso, Hiroyasu
author_facet Hirosaki, Mayumi
Ohira, Tetsuya
Wu, Yawei
Eguchi, Eri
Shirai, Kokoro
Imano, Hironori
Funakubo, Narumi
Nishizawa, Hitoshi
Katakami, Naoto
Shimomura, Iichiro
Iso, Hiroyasu
author_sort Hirosaki, Mayumi
collection PubMed
description BACKGROUND: Laughter has been reported to have various health benefits. However, data on the long-term effects of laughter interventions on diabetes are limited. This study aimed to investigate whether laughter yoga can improve glycemic control among individuals with type 2 diabetes. METHODS: In a single-center, randomized controlled trial, 42 participants with type 2 diabetes were randomly assigned to either the intervention or the control group. The intervention consisted of a 12-week laughter yoga program. Hemoglobin A1c (HbA1c), body weight, waist circumference, psychological factors, and sleep duration were evaluated at baseline and week 12. RESULTS: Intention-to-treat analysis showed that participants in the laughter yoga group experienced significant improvements in HbA1c levels (between-group difference: −0.31%; 95% CI −0.54, −0.09) and positive affect scores (between-group difference: 0.62 points; 95% CI 0.003, 1.23). Sleep duration tended to increase in the laughter yoga group with a between-group difference of 0.4 hours (95% CI −0.05, 0.86; P = 0.080). The mean attendance rate for laughter yoga program was high (92.9%). CONCLUSIONS: A 12-week laughter yoga program is feasible for individuals with type 2 diabetes and improves glycemic control. These findings suggest that having fun could be a self-care intervention. Further studies with larger numbers of participants are warranted to better evaluate the effects of laughter yoga. CLINICAL TRIAL REGISTRATION: http://www.chinadrugtrials.org.cn, identifier UMIN000047164.
format Online
Article
Text
id pubmed-10102335
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101023352023-04-15 Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial Hirosaki, Mayumi Ohira, Tetsuya Wu, Yawei Eguchi, Eri Shirai, Kokoro Imano, Hironori Funakubo, Narumi Nishizawa, Hitoshi Katakami, Naoto Shimomura, Iichiro Iso, Hiroyasu Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Laughter has been reported to have various health benefits. However, data on the long-term effects of laughter interventions on diabetes are limited. This study aimed to investigate whether laughter yoga can improve glycemic control among individuals with type 2 diabetes. METHODS: In a single-center, randomized controlled trial, 42 participants with type 2 diabetes were randomly assigned to either the intervention or the control group. The intervention consisted of a 12-week laughter yoga program. Hemoglobin A1c (HbA1c), body weight, waist circumference, psychological factors, and sleep duration were evaluated at baseline and week 12. RESULTS: Intention-to-treat analysis showed that participants in the laughter yoga group experienced significant improvements in HbA1c levels (between-group difference: −0.31%; 95% CI −0.54, −0.09) and positive affect scores (between-group difference: 0.62 points; 95% CI 0.003, 1.23). Sleep duration tended to increase in the laughter yoga group with a between-group difference of 0.4 hours (95% CI −0.05, 0.86; P = 0.080). The mean attendance rate for laughter yoga program was high (92.9%). CONCLUSIONS: A 12-week laughter yoga program is feasible for individuals with type 2 diabetes and improves glycemic control. These findings suggest that having fun could be a self-care intervention. Further studies with larger numbers of participants are warranted to better evaluate the effects of laughter yoga. CLINICAL TRIAL REGISTRATION: http://www.chinadrugtrials.org.cn, identifier UMIN000047164. Frontiers Media S.A. 2023-03-31 /pmc/articles/PMC10102335/ /pubmed/37065750 http://dx.doi.org/10.3389/fendo.2023.1148468 Text en Copyright © 2023 Hirosaki, Ohira, Wu, Eguchi, Shirai, Imano, Funakubo, Nishizawa, Katakami, Shimomura and Iso https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Hirosaki, Mayumi
Ohira, Tetsuya
Wu, Yawei
Eguchi, Eri
Shirai, Kokoro
Imano, Hironori
Funakubo, Narumi
Nishizawa, Hitoshi
Katakami, Naoto
Shimomura, Iichiro
Iso, Hiroyasu
Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial
title Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial
title_full Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial
title_fullStr Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial
title_full_unstemmed Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial
title_short Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial
title_sort laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: a randomized controlled trial
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102335/
https://www.ncbi.nlm.nih.gov/pubmed/37065750
http://dx.doi.org/10.3389/fendo.2023.1148468
work_keys_str_mv AT hirosakimayumi laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT ohiratetsuya laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT wuyawei laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT eguchieri laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT shiraikokoro laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT imanohironori laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT funakubonarumi laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT nishizawahitoshi laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT katakaminaoto laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT shimomuraiichiro laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial
AT isohiroyasu laughteryogaasanenjoyabletherapeuticapproachforglycemiccontrolinindividualswithtype2diabetesarandomizedcontrolledtrial